EpiVax, Inc. - Informatics and Immunology
  • Our Company
    • Company Overview
    • Corporate Responsibility
    • Mission, Vision & Values
    • Team
    • Careers
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • BioDefense Vaccines
    • Tregitope: Immunomodulation Power Tool
    • Deimmunization Projects
  • Vaccine Services
    • Vaccine Services
    • iVAX: Web-based Vaccine Design
    • PreVAX Analysis
    • EpiCC
  • Immunogenicity Assessment
    • Immunogenicity Assessment Overview
    • ISPRI Web-based Immunogenicity Assessment
    • PreDeFT Analysis
    • High Throughput Immunogenicity Analysis
    • PANDA Screening
    • ISPRI for Host Cell Proteins
    • Deimmunization
    • Trusted Expert Advice (TEA) Consulting Services
  • Lab Services
    • Lab Services Overview
    • HLA Binding Assays
    • T Cell Assays
  • Press Room
    • Press Room
    • Events
      • Webinars
    • Publication & Poster Search
    • Client Testimonials
    • Thinking Out Loud (Blog)
    • Recipes For Success (Podcast)
  • Contact Us
Select Page
Amsterdam Immunogenicity & Tolerance Seminar November 18, 2022 **Updated with Pictures and Recordings!****

Amsterdam Immunogenicity & Tolerance Seminar November 18, 2022 **Updated with Pictures and Recordings!****

by Riley Nolan | Nov 18, 2022 | Events, Featured

A big THANK YOU to everyone who participated in the EpiVax’s 2022 Immunogenicity & Tolerance Seminar in Willemspark, Amsterdam, organized with Corine Kruiswijk of Intravacc. We learned about the importance of tissue-resident T memory cells, new developments in...
EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine

EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine

by Riley Nolan | Oct 31, 2022 | Featured, News

EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine PROVIDENCE, RI, October 31, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for...
AAPS PharmSci 360, October 16-19, 2022  **Updated with Pictures!**

AAPS PharmSci 360, October 16-19, 2022 **Updated with Pictures!**

by Riley Nolan | Oct 17, 2022 | Events, Featured

We had a blast at AAPS PharmSci 360 in Boston! Thank you to everyone that attended our talks and poster sessions, and stopped by our booth or cocktail reception at Legal Seafoods! Pictures below!   Talks:  Anne De Groot, M.D., EpiVax, Inc. Deimmunization and...
Tokyo Giants and Gene Therapy Cowboys

Tokyo Giants and Gene Therapy Cowboys

by Riley Nolan | Sep 22, 2022 | Featured, Thinking Out Loud -Blog

FDA Awards $2M in Funding to EpiVax Host Cell Protein Study Remember when the CHO genome sequence came out? Ok, so you don’t, but we do! We built an app for that (see our paper entitled “Of [Hamsters] and Men”) and so, we will now perform validating...
EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine

EpiVax Secures Additional Funding from FDA for Immunogenicity Risk Assessment for Biosimilar Products

by Riley Nolan | Sep 12, 2022 | Featured, News

PROVIDENCE, RI, September 12, 2022 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) is pleased to announce the award of a two-year, $2 million grant from the FDA’s Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk...
« Older Entries

Recent Posts

  • From Kyoto, with Love
  • EpiVax Turns 25!
  • Happy Valentine’s Day! And don’t argue with Chatbots!
  • ISPRI in silico Toolkit in the Literature
  • Platform shoes, Bellbottoms and #CrueltyFreeFDA!

Categories

  • EpiVax Immunoncology
  • Events
  • Featured
  • News
  • Recipes for Success – Vlog
  • Thinking Out Loud -Blog
  • Uncategorized
  • Webinars

Discover

  • Vaccine Services
  • Immunogenicity Assessment
  • Deimmunization
  • Lab Services
  • Pipeline

About

  • Our Company
  • Press Room
  • Events
  • Publication & Poster Search
  • Thinking Out Loud (Blog)
  • Contact Us

Connect

© 2023 EpiVax, Inc. – Informatics and Immunology, All rights reserved. Privacy Policy • 188 Valley Street, Suite 424, Providence, RI 02909 • ph: 401.272.2123 • fax: 401.272.7562